PUBLICATIONS · 12149296
Phase II evaluation of low-dose oral etoposide for the treatment of relapsed or progressive AIDS-related Kaposi's sarcoma: an AIDS Clinical Trials Group clinical study.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2002 Aug 1
- First author
- Evans SR
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Evans SR
- type
- Author
- name
- Krown SE
- type
- Author
- name
- Testa MA
- type
- Author
- name
- Cooley TP
- type
- Author
- name
- Von Roenn JH
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Evans SR
- type
- Author
- name
- Krown SE
- type
- Author
- name
- Testa MA
- type
- Author
- name
- Cooley TP
- type
- Author
- name
- Von Roenn JH
- type
- Author
- bibliography ids
- nci-bib-8c846b7d7d92ca39f9902f75
- book metadata
- content sha256
- f9dca638c5417f7b86be540c770467fe0a9cf13f1bd4d5b434c344ee2da5be67
- document type
- citation
- dois
- 10.1200/JCO.2002.12.038
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:12149296
- immutable id
- pubmed:12149296@f9dca638c5417f7b86be540c770467fe0a9cf13f1bd4d5b434c344ee2da5be67
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- Source null
- issn print
- 0732-183X
- issue
- 15
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 3236-41
- volume
- 20
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 12149296
- provenance
- batch id
- ced7794d3512d3f45188
- provider
- NCBI PubMed ESummary
- record sha256
- a604e305bd2265bda8737e51160fea0eb15cd1e297b11cb2f34c03f50347ca8a
- response sha256
- 782bfef1f051086807ee9551561575ae64b9ca1f941a87d5259ff83e5424435e
- retrieved at
- 2026-09-09T23:45:46.208577+00:00
- publication date
- display
- 2002 Aug 1
- precision
- day
- year
- 2002
- publication types
- Clinical Trial
- Clinical Trial, Phase II
- Journal Article
- Research Support, U.S. Gov't, P.H.S.
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Phase II evaluation of low-dose oral etoposide for the treatment of relapsed or progressive AIDS-related Kaposi's sarcoma: an AIDS Clinical Trials Group clinical study.
Preserved source evidence · Not medical advice
Triangle